Seth Lowry
Direttore/Membro del Consiglio presso Cardea Bio, Inc.
Profilo
Seth Lowry is currently a Director at Cardea Bio, Inc. and a Director of Research at Wingspan Capital LLC.
He received his undergraduate degree from the University of Colorado Boulder in 2007.
Posizioni attive di Seth Lowry
| Società | Posizione | Inizio |
|---|---|---|
Cardea Bio, Inc.
 Cardea Bio, Inc. BiotechnologyHealth Technology Cardea Bio, Inc. develops bioelectronics for use in research and diagnostics. Its products include AGILE 100 and pipeline. The company was founded by Ross Bundy, Kiana Aran, and Brett Goldsmith in 2013 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | - |
Wingspan Capital LLC
 Wingspan Capital LLC Investment ManagersFinance Wingspan Capital LLC (Wingspan Capital) is a private equity firm founded in 2019 by Andrew Eberhart. The firm is headquartered in New York. | Direttore/Membro del Consiglio | 01/12/2022 |
Formazione di Seth Lowry
| University of Colorado Boulder | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Cardea Bio, Inc.
Cardea Bio, Inc. BiotechnologyHealth Technology Cardea Bio, Inc. develops bioelectronics for use in research and diagnostics. Its products include AGILE 100 and pipeline. The company was founded by Ross Bundy, Kiana Aran, and Brett Goldsmith in 2013 and is headquartered in San Diego, CA. | Health Technology |
Wingspan Capital LLC
Wingspan Capital LLC Investment ManagersFinance Wingspan Capital LLC (Wingspan Capital) is a private equity firm founded in 2019 by Andrew Eberhart. The firm is headquartered in New York. | Finance |
- Borsa valori
- Insiders
- Seth Lowry
